The Cancer Care Gap & The 90-Day Blind Spot
Modern medicine has perfected the science of the 15-minute appointment, yet leaves patients navigating a 90-day physiological chasm where acute oncological deterioration remains clinically invisible until disaster strikes.
Approximately 70% of the global adult population will navigate at least one debilitating chronic disease or malignancy during their lifetime. Yet, regardless of whether a patient is receiving high-potency cytotoxic chemotherapy, bispecific antibody infusions, or oral targeted tyrosine kinase inhibitors, modern medical infrastructure allocates them an average of just 15 minutes of direct physician face-time every one to three months. In the intervening 30 to 90 days, clinical medicine goes completely dark. This protracted void is known across health systems engineering as the surveillance gap—a systemic structural failure in outpatient care where progressive physiological destabilization unfolds entirely unrecorded.
Inside this clinical blind spot, a cancer patient experiences more than 1,000 discrete physiological events every twenty-four hours. Resting heart rates accelerate under occult volume contraction; subtle nocturnal desaturations flag early pulmonary toxicity; micro-elevations in core body temperature announce neutropenic infection hours before shaking chills begin; and severe neuropathic pain or intractable nausea compounds silently. Because standard outpatient oncology relies almost entirely on retrospective patient recall during the subsequent quarterly visit, patients are forced to compress weeks of complex, multi-system decline into a rushed, subjective summary. Vital early warnings are dismissed, forgotten, or rationalized away until physiological collapse triggers an emergency room admission, an intensive care unit (ICU) transfer, or permanent treatment discontinuation.
Drag the timeline scrubber across the 90-day post-chemotherapy inter-visit period to contrast standard episodic oncology against CareHub's continuous surveillance stream.
OnCo: Mapping the Architecture of Oncology
Democratizing complex oncology through a 22,000-node public knowledge graph that bridges molecular biology, drug discovery pipelines, and active clinical trials in plain language.
While continuous physiological tracking solves the inter-visit data void, telemetry without domain context is clinically paralyzed. A rise in resting heart rate or acute platelet destruction carries vastly divergent clinical meanings depending on whether a patient is receiving checkpoint inhibitors, anti-angiogenic agents, or targeted antibody-drug conjugates. This is where OnCo (onco.cc), created by Jude Gomila, establishes total information clarity. OnCo is an open, cited, highly interconnected knowledge graph mapping 474 distinct cancers, 1,059 targeted treatments and diagnostic tests, 6,086 clinical trials, 1,694 biological targets, 109 molecular pathways, and 1,245 biotechnology organizations.
Distributed under open-source MIT code and CC BY-NC 4.0 data licenses, OnCo dismantles the severe information asymmetry that has historically characterized cancer care. Crucial oncology intelligence—such as cytogenetic stratification in multiple myeloma, resistance mutations to EGFR inhibitors, or antibody-drug conjugate (ADC) toxicity profiles—has traditionally remained locked behind paywalled academic journals or sequestered within tertiary academic medical centers. OnCo structures every entity with a plain-English translation at the surface, anchored immediately to verified peer-reviewed citations, molecular structures, and active trial pipelines. Delivered through a lightning-fast static JSON API, an open MCP server, and command-line interfaces, OnCo functions as a universal reference spine accessible to patients, family caregivers, and community oncologists alike.
Select a clinical disease entity from OnCo's corpus to explore how molecular targets, guideline-approved therapies, and anticipated toxicities link to inter-visit monitoring protocols:
Multiple Myeloma (Plasma Cell Dyscrasia)
By linking biomarkers directly to targeted therapies—such as osimertinib for EGFR exon 19 deletions or trastuzumab deruxtecan for HER2-positive expression—OnCo establishes the definitive scientific ground truth. As oncology evolves from empirical chemotherapeutic blunt instruments to precision genomic pairing, OnCo provides the foundational roadmap: outlining what is FDA-approved, what is backed by National Comprehensive Cancer Network guidelines, and what experimental agents are recruiting across 6,000 active clinical trials. When integrated with continuous patient tracking, OnCo gives physiological numbers immediate biological context.
CareHub: The Deterministic Telemetry Engine
Engineering a privacy-first, zero-AI measurement layer that guarantees clinical data integrity, paired with upstream algorithmic synthesis to banish automation bias.
CareHub was founded by David Lennard after slipping through health insurance cracks in 2019 and navigating an aggressive multiple myeloma diagnosis in solitary isolation during the pandemic. Recognizing that cancer patients were drowning in uncoordinated patient portals and fragmented symptom journals while physicians remained starved for longitudinal data, Lennard engineered CareHub as a free, privacy-first operating layer designed specifically to close the 90-day inter-visit chasm.
The foundational engineering tenet of CareHub is its strict architectural separation between the measurement layer and the interpretation layer. In an era where consumer health applications haphazardly inject large language models into vital sign collection, CareHub mandates zero artificial intelligence in the vitals layer itself. Physical biometrics—resting heart rate, respiratory rate, blood oxygen saturation, blood pressure, blood glucose, and skin temperature—are treated as sacrosanct physiological ground truth. They are captured through deterministic, medical-grade Bluetooth/cellular sensor patches or strict manual-entry guardrails with hard boundary validations. No probabilistic machine learning model is ever permitted to smooth, extrapolate, or hallucinate patient telemetry.
Click on each architectural layer to inspect how CareHub guarantees clinical data provenance while preventing automation bias:
- Medical-Grade Wearables: 1,440 automated vital transmissions/day (BioButton, VitalPatch, Sensium).
- Boundary Validation: Rigid physiological sanity checks (e.g., RR 4–60 bpm, SpO2 50–100%).
- 114 Language Localizations: Public beta — native terminology verification in progress.
- Clinical Ground Truth: Immutable time-series log stored securely on local client.
- Contextual Pattern Matching: Cross-references vitals against OnCo toxicity signatures.
- MEWS Scoring: Algorithmic early warning detection for neutropenic infection or sepsis.
- 10-Second Visual Summary: Synthesizes 90 days of drift into a single-page physician PDF.
- Automation Bias Guard: AI suggestions are clearly labeled as machine inferences.
Clinicians routinely reject digital health logs when artificial intelligence alters raw data. By guaranteeing that every vital sign is an unaltered, verifiable human or sensor observation, CareHub preserves complete evidentiary chain of custody. Artificial intelligence acts solely as a high-speed clinical scribe and pattern detector above the data, ensuring the physician remains the ultimate decision-maker.
CareHub's output mechanism is deliberately optimized for the high-friction realities of clinical workflows. Rather than forcing overloaded oncologists to navigate another proprietary software dashboard, CareHub compiles patient-reported telemetry into clean, exportable PDF tracking calendars and an executive one-page 10-second graphical snapshot. Patients can physically hand this document to their physician or upload it directly to institutional portals, enabling the clinician to instantly grasp three months of trends without spending precious minutes on manual data extraction.
Tracking Post-Diagnosis Metrics: Beyond Physical Vitals
Deconstructing cancer recovery into a multi-parameter surveillance framework encompassing autonomic vitals, electronic patient-reported outcomes (ePROs), and neurocognitive health.
Malignancy is rarely an isolated physiological event. Effective inter-visit surveillance requires capturing the interplay between autonomic regulation, acute toxicities, somatic symptoms, and neurocognitive distress. Standard vital signs alone cannot capture an impending opioid-induced delirium, nor can a simple temperature check register bone marrow infiltration. CareHub structures post-diagnosis monitoring across three synchronized domains:
1. Autonomic & Physical Vitals: Continuous heart rate variability (HRV), resting pulse, respiratory rate (the single most sensitive herald of metabolic acidosis and pulmonary deterioration), blood oxygen saturation, blood pressure, and core temperature micro-trends. Continuous temperature tracking captures subtle sub-febrile elevations (37.8°C to 38.2°C) up to 14 hours ahead of frank neutropenic bacteremia.
2. Anatomical Pain & Somatic ePROs: Electronic Patient-Reported Outcomes (ePROs) integrating validated Common Terminology Criteria for Adverse Events (CTCAE) grades for nausea, emesis, and diarrhea, combined with interactive anatomical body maps. In multiple myeloma, tracking localized bone pain allows immediate differentiation between benign musculoskeletal fatigue and pathological vertebral fracture.
3. Neurocognitive & Psychological Health: Longitudinal tracking of sleep architecture fragmentation, generalized anxiety (GAD-7), and depression (PHQ-2/9). In large cohort studies of chronic illness, comorbid depression occurs in 12.7% of patients and is an independent predictor of premature all-cause mortality (adjusted Hazard Ratio 1.21 to 1.33, P<0.05).
In a Canadian retrospective cohort study of 36,211 multi-morbid patients by Su et al. (2025), high medication adherence (PDC ≥ 80%) was proven to slash all-cause mortality by 33% for antidiabetic therapies (aHR 0.67, P=0.001) and 32% for statins (aHR 0.68, P<0.001), while producing statistically significant reductions in diastolic blood pressure and LDL cholesterol. Yet, concurrent adherence to multiple medications was achieved by only 11.1% of patients! Digital vitals tracking creates an active feedback loop that more than doubles the odds of medication adherence (Odds Ratio 2.11), directly converting home tracking into long-term survival.
By combining physical telemetry with subjective patient feedback, CareHub prevents both unintentional non-adherence (forgetfulness or regimen complexity) and intentional non-adherence (stopping medication due to unmanaged toxicities). The clinician receives a comprehensive, 360-degree biometric narrative that reflects the patient's lived physiological reality.
Empowering Remote Family Doctors & Rural Caregivers
Filtering thousands of raw wearable data points into prioritized clinical triage, equipping frontline general practitioners to prevent emergency department crises.
The fundamental failure of early remote monitoring programs was not a lack of data; it was an overwhelming deluge of uncurated noise. In large-scale clinical trials of remote cardiac telemetry, 26,000 patients generated over 205,000 transmissions in a single year, of which fewer than 3% required acute physician intervention. For remote family physicians, community health nurses, and isolated rural caregivers, receiving hundreds of unstratified heart rate notifications daily leads directly to alert fatigue, burnout, and clinical abandonment.
CareHub resolves this systemic bottleneck by serving as an intelligent clinical triage filter. Rather than streaming raw sensor noise directly to the provider, CareHub's edge algorithms filter daily vitals through validated early warning protocols (such as the Modified Early Warning Score, MEWS). Physiological instability is categorized into clear tiers: green (in therapeutic baseline), amber (subtle drift warranting caregiver check-in), and red (acute clinical escalation requiring physician contact). This architecture transforms raw numbers into actionable clinical decisions.
Model the clinical and financial outcomes of deploying continuous surveillance across an oncology or chronic illness patient cohort:
The real-world financial and clinical efficacy of this approach is firmly grounded in academic literature. Broad systematic reviews of 40 randomized controlled trials demonstrate that remote patient monitoring achieves a 14% reduction in overall hospitalization risk (Risk Ratio 0.86, 95% CI: 0.77 to 0.95) and an average hospital length of stay reduction of -0.84 days. In COVID-19 cohorts, home oximetry programs reduced patient mortality from 1.7% to 0.5% while slashing care costs from $3,565.97 down to $2,306.33 per patient. For rural general practitioners hours away from oncology centers, CareHub turns isolated family members into confident care partners, capable of recognizing decompensation and initiating tele-triage before an emergency unfolds.
Clinical Workflow Integration: From Legacy HL7 to Modern FHIR
Eliminating clinical transcription burden by streaming standardized JSON resources directly into institutional EHRs, powered by federal interoperability mandates.
A continuous tracking platform is clinically inert if its data cannot traverse the enterprise electronic health record (EHR) firewall. Historically, healthcare integration was crippled by legacy Health Level Seven (HL7) version 2 and version 3 standards. Built in the late 1980s, HL7 v2 relied on rigid, pipe-and-caret delimited message segments (such as MSH|^~\&|, PID|||, OBX|||). These monolithic message blocks required complex, customized point-to-point interface engines, imposed massive implementation overhead, and were incapable of handling high-frequency streaming telemetry from consumer wearables or home hubs. Vital signs remained trapped in proprietary silos.
CareHub solves enterprise integration by adopting modern Fast Healthcare Interoperability Resources (FHIR R4). Designed natively around RESTful APIs, JSON payloads, and OAuth 2.0 authentication, FHIR breaks clinical concepts into modular, reusable building blocks: Patient, Observation, Condition, MedicationStatement, and Encounter. Accelerated by federal mandates from the Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator (ONC), FHIR allows CareHub to securely write discrete physiological observations directly into hospital systems like Epic, Cerner, and Meditech without requiring custom code or manual nursing transcription.
Toggle between legacy pipe-delimited HL7 v2 and modern RESTful FHIR R4 to observe how CareHub structures continuous vitals for seamless EHR ingestion:
By utilizing standard LOINC codes (e.g., 8867-4 for Heart Rate, 8310-5 for Body Temperature), institutional EHRs can ingest CareHub telemetry automatically. The data populates clinical trend graphs and triggers automated MEWS alerts inside the physician's existing workflow, completely eliminating the need for clinicians to log into third-party portals.
Furthermore, embedding Modified Early Warning Scores directly into EHR workflows has been proven to significantly reduce out-of-ICU cardiac arrests and unplanned admissions. Steitz et al. and Udod et al. demonstrated that EHR-embedded early warning algorithms improve multidisciplinary communication, accelerate nurse-physician escalations, and decrease time to resuscitation. FHIR provides the open architectural bridge connecting continuous home telemetry to hospital response teams.
Global Health Equity, Multi-Morbidity & Low-Bandwidth Architecture
Deploying a 114-language localization layer (public beta, verification ongoing) on low-bandwidth Next.js web architecture to bring continuous cancer tracking to underserved populations worldwide.
Cancer and chronic disease are global crises characterized by catastrophic disparities in access. Over 70% of global cancer deaths occur in low- and middle-income countries, where tertiary oncologists are virtually non-existent and patients travel days to reach a regional clinic. In high-income nations, ethnic and linguistic minorities experience severe disparities in early detection, clinical trial enrollment, and survival. Digital health technologies frequently exacerbate these inequities by requiring high-end smartphones, reliable high-speed broadband, and English fluency.
CareHub was intentionally engineered to dismantle this digital divide. The platform features an extensive 114-language localization layer currently in public beta while native-speaking cultural ambassadors complete verification of local medical terminology. Rather than relying on inaccurate machine translation that distorts nuanced symptoms, CareHub is working through languages ranging from Swahili, Hindi, and Tagalog to Quechua, Arabic, and Vietnamese. A rural community healthcare worker in sub-Saharan Africa or a non-English-speaking caregiver in urban North America will be able to interact with the system in their native mother tongue once verification is complete.
CareHub’s localization layer is in public beta while native speakers complete verification of medical terminology. The architecture is engineered to transmit in sub-15KB payloads over 2G/3G cellular networks.
Crucially, CareHub's architecture scales seamlessly across major chronic disease crossovers. Malignancy rarely exists in a vacuum: elderly cancer patients frequently manage comorbid hypertension, type 2 diabetes, chronic obstructive pulmonary disease (COPD), or Long COVID autonomic dysfunction. By uniting OnCo's open scientific knowledge mapping with CareHub's universal, lightweight telemetry layer, the paradigm of chronic illness management shifts: from an exclusionary, English-centric, episodic privilege into an equitable, continuous global right.
Primary Sources & Literature Registry
Complete academic citations, clinical trial publications, health informatics standards, and platform blueprints supporting continuous inter-visit surveillance and open oncology mapping.